The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit.
Costanza TripicianoLorenza RomaniStefania MercadanteLaura CursiMartina Di GiuseppeFrancesca Ippolita Calo CarducciTiziana FragassoLuca Di ChiaraCristiana GaristoAnnamaria SistoLeonardo VallesiValentino CostabileLaura LancellaPaola BernaschiMaia De LucaPublished in: Antibiotics (Basel, Switzerland) (2023)
The increase over the years of MBL-producing pathogens in our hospital is challenging in terms of therapeutic options. According to the present study, N-CEFs are a safe and effective option in pediatric patients affected by CRO infections.